During a live event, Alexander I. Spira, MD, PhD, and participants discuss efficacy, adverse events, and sequencing of EGFR-mutated NSCLC treatments.

The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely ...

Liver fibrosis is a major global health concern, developing as a result of chronic liver diseases (CLDs) such as viral ...

Marwan G. Fakih, MD, discusses the next steps for the clinical development of the balstilimab plus botensilimab in ...

Plus Therapeutics (PSTV) soars with FDA's Orphan Drug Designation for Rhenium Obisbemeda, targeting rare leptomeningeal metastases.

Scientists have uncovered the mechanism behind how aspirin could reduce the metastasis of some cancers by stimulating the ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

Plectin drives hepatocellular carcinoma progression and metastasis through cytoskeletal reorganization and oncogenic signaling, making it a promising therapeutic target for overcoming therapy ...

Treatment with thermal ablation was noninferior to surgical resection in small-size colorectal liver metastases, according to ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced stages when the disease has already spread, or metastasized. About half of ...